2 Day Biosimilars Training Course: Global Overview of Biosimilars and how they Differ from the Original Biological Product (October 11-12, 2022)
28 sept. 2022 08h03 HE
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Biosimilars Training Course" conference has been added to ResearchAndMarkets.com's offering. This seminar will provide you with a global overview...
Trastuzumab Biosimilars Global Market Report 2022: Focus on Product Launches by Major Players Shaping Industry
27 sept. 2022 04h58 HE
|
Research and Markets
Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2022: By Product, By Indication, By Distribution" report has been added to ResearchAndMarkets.com's...
Global Biosimilars Market Report 2022: Cost-Savings with No Reductions in Care Quality Driving Adoption
20 sept. 2022 05h28 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Biosimilars Market Size, Share, Trends, By Product Type, By Disease Type, and By Region Forecast to 2030" report has been added to ...
Global Biosimilars Market Report 2022: Lower Prices Compared to Branded Products Driving $16.48 Billion Industry
14 sept. 2022 05h08 HE
|
Research and Markets
Dublin, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market (2022 Edition) - Analysis By Product Type, Application, By Region, By Country: Market Insights and Forecast with Impact of...
Global Biosimilars Market Research Report 2022: Strong Pipeline of Drugs, Low Cost of Biosimilars and an Increase in Patent Expiration
01 sept. 2022 07h13 HE
|
Research and Markets
Dublin, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The "Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering.The global biosimilars...
Rituximab Biosimilars Global Market Report 2022: Major Players Collaboration in Development Driving Sector Forward
09 août 2022 05h28 HE
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Rituximab Biosimilars Global Market Report 2022: By Application, By Distribution, By Route" report has been added to ResearchAndMarkets.com's offering....
US Biosimilar Market Report 2022: Featuring Key Players Pfizer, Novartis AG, Amgen, Samsung Biologics, Celltrion & Viatris
26 juil. 2022 06h53 HE
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "US Biosimilar Market: Insights & Forecast with Potential Impact of COVID- 19 (2022-2026)" report has been added to ResearchAndMarkets.com's...
European Biosimilar Market Report 2022-2027: Featuring Key Players Novartis, Pfizer, Samsung Bioepis & Others
04 juil. 2022 06h33 HE
|
Research and Markets
Dublin, July 04, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Biosimilars Partnering Terms and Agreements 2010 to 2022: Trends in Biosimilars Dealmaking in the Biopharma Industry since 2010
27 juin 2022 06h58 HE
|
Research and Markets
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. This report is intended...
Global Biosimilar Monoclonal Antibodies Market Report 2022: Market is Expected to Reach $10.64 Billion in 2026 at a CAGR of 18.1% - Long-term Forecast to 2031
01 juin 2022 05h13 HE
|
Research and Markets
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Monoclonal Antibodies Global Market Report 2022: By Type, By Application, By Compound" report has been added to ResearchAndMarkets.com's...